Considerations for successful transplantation of encapsulated pancreatic islets P. de VosA. F. HamelK. Tatarkiewicz Reviews 03 May 2014 Pages: 159 - 173
Uncoupling protein-2: evidence for its function as a metabolic regulator M. C. SalehM. B. WheelerC. B. Chan Review 03 May 2014 Pages: 174 - 187
A phosphodiesterase inhibitor, cilostazol, prevents the onset of silent brain infarction in Japanese subjects with Type II diabetes T. Shinoda-TagawaY. YamasakiM. Hori Articles 03 May 2014 Pages: 188 - 194
The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men H. AgersøL. B. JensenM. Zdravkovic Article 03 May 2014 Pages: 195 - 202
Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy I. M. Hogeboom van BuggenumB. C. P. PolakG. J. Tangelder Article 03 May 2014 Pages: 203 - 209
Relation between glycaemic control, hyperinsulinaemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or Type II diabetes M. BlüherR. UngerR. Paschke Article 03 May 2014 Pages: 210 - 216
Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes A. J. K. WilliamsP. J. Bingleyand the ENDIT Screening Group Article 03 May 2014 Pages: 217 - 223
Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice A. M. J. ShapiroW. L. Suarez-PinzonA. Rabinovitch Article 03 May 2014 Pages: 224 - 230
Syntaxin-3 and syntaxin-1A inhibit L-type calcium channel activity, insulin biosynthesis and exocytosis in beta-cell lines Y. KangX. HuangH. Y. Gaisano Article 03 May 2014 Pages: 231 - 241
Metabotropic glutamate and GABAB receptors contribute to the modulation of glucose-stimulated insulin secretion in pancreatic beta cells N. L. BriceA. VaradiE. Molnar Article 03 May 2014 Pages: 242 - 252
Kidney function and glomerulopathy over 8 years in young patients with Type I (insulin-dependent) diabetes mellitus and microalbuminuria H.-J. BangstadR. ØsterbyK. F. Hanssen Article 03 May 2014 Pages: 253 - 261
Kinetics of integrin expression in the mouse model of proliferative retinopathy and success of secondary intervention with cyclic RGD peptides E. ChavakisB. RieckeH.-P. Hammes Article 03 May 2014 Pages: 262 - 267
Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases S. V. McLennanD. J. KellyR. E. Gilbert Article 03 May 2014 Pages: 268 - 275
Polymorphism in the Calpain 10 gene influences glucose metabolism in human fat cells J. HoffstedtM. RydénP. Arner ARTICLE 03 May 2014 Pages: 276 - 282
Adult-onset idiopathic Type I or ketosis-prone Type II diabetes: evidence to revisit diabetes classification E. SobngwiJ.-F. Gautier For debate 03 May 2014 Pages: 283 - 285
- to: Lindner T, Cockburn BN, Bell GI (1999) Molecular genetics of MODY in Germany. Diabetologia 42: 121–123 F. ZiemssenC. Bellanné-ChantelotA.F.H. Pfeiffer Letters 30 April 2014 Pages: 286 - 287
- to: T. J. Wilkin (2001) The accelerator hypothesis: weight gain as the missing link between Type I and Type II diabetes. Diabetologia 44: 914–921 F. K. GorusI. WeetsD. G. Pipeleers Letters 30 April 2014 Pages: 288 - 289
Complete glucokinase deficiency is not a common cause of permanent neonatal diabetes A. L. GloynS. EllardA. T. Hattersley Letters to the editor 30 April 2014 Pages: 290 - 290
Losartan attenuates endothelial hyperpermeability responses to VPF and high glucose but not angiotensin II I. IdrisN. TyremanR. Donnelly Letters to the editor 30 April 2014 Pages: 291 - 292
Erratum to: Advanced glycation end-products: a review R. SinghA. BardenL. Beilin Erratum 30 April 2014 Pages: 293 - 293